"Many supplements have real biologic effects, and when you layer them on top of blood thinners, you can tip into either ...
The National Institutes of Health (NIH) on Tuesday discontinued the low-dose rivaroxaban arm of its ongoing Phase 3 CAPTIVA ...
More than 8 million people in the U.S. take blood thinners to prevent dangerous clots. At the same time, the drugs are ...
FDA-approved Andexxa reversed Xarelto and Eliquis bleeding but was linked to higher rates of blood clots and death, ...
Bristol Myers Squibb delivered better than expected fourth quarter earnings, but Eliquis missed expectations while Cobenfy ...
Bristol Myers Squibb on Thursday delivered strong fourth quarter results — and better yet, issued a 2026 forecast that was ...
By Michael Erman Feb 5 (Reuters) - Bristol Myers Squibb on Thursday forecast 2026 results above Wall Street estimates, saying ...
Bristol Myers Squibb on Thursday forecast 2026 revenue and profit above Wall Street estimates, saying that price cuts to its ...
Christian Barmore was diagnosed with life-threatening blood clots in 2024 but returned to play every game this season under ...
Drugmakers are doing something unusual this year: slashing prices for several widely used medicines. The companies made their typical round of price increases to start the year. In addition, they also ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results